IMAC HOLDINGS INC (BACK) Stock Price, Quote, News and Overview
NASDAQ:BACK - Nasdaq - US44967K3023 - Common Stock - Currency: USD
BACK Quote, Performance and Key Statistics
0.656
-0.04 (-6.15%)
The current stock price of BACK is 0.656 USD. In the past month the price decreased by -15.9%. In the past year, price decreased by -55.07%.
BACK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 14.3 | 80.15B | ||
| BKDT | BROOKDALE SENIOR LIVING - BKD 7 11/15/25 | N/A | 14.59B | ||
| THC | TENET HEALTHCARE CORP | 10.89 | 12.32B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 12.12 | 11.88B | ||
| EHC | ENCOMPASS HEALTH CORP | 22.02 | 9.83B | ||
| ENSG | ENSIGN GROUP INC/THE | 22.97 | 7.26B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 11.3 | 3.68B | ||
| SGRY | SURGERY PARTNERS INC | 26.93 | 3.22B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 8.6 | 2.92B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 9.02 | 2.28B | ||
| PACS | PACS GROUP INC | 16.83 | 1.98B | ||
| ARDT | ARDENT HEALTH PARTNERS INC | 36.58 | 1.98B |
Related stock screener links
About BACK
Company Profile
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Franklin, Tennessee and currently employs 2 full-time employees. The company went IPO on 2019-02-13. The firm is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The firm is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The firm is also engaged in providing the precision medicine business. The firm's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
Company Info
IMAC HOLDINGS INC
3401 Mallory Lane, Suite 100
Franklin TENNESSEE US
Employees: 2
Company Website: https://imacregeneration.com/
Investor Relations: https://ir.imacregeneration.com/
Phone: 18442664622
IMAC HOLDINGS INC / BACK FAQ
What is the stock price of IMAC HOLDINGS INC today?
The current stock price of BACK is 0.656 USD. The price decreased by -6.15% in the last trading session.
What is the ticker symbol for IMAC HOLDINGS INC stock?
The exchange symbol of IMAC HOLDINGS INC is BACK and it is listed on the Nasdaq exchange.
On which exchange is BACK stock listed?
BACK stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for IMAC HOLDINGS INC stock?
7 analysts have analysed BACK and the average price target is 8.41 USD. This implies a price increase of 1182.77% is expected in the next year compared to the current price of 0.656. Check the IMAC HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is IMAC HOLDINGS INC worth?
IMAC HOLDINGS INC (BACK) has a market capitalization of 1.36M USD. This makes BACK a Nano Cap stock.
How many employees does IMAC HOLDINGS INC have?
IMAC HOLDINGS INC (BACK) currently has 2 employees.
What are the support and resistance levels for IMAC HOLDINGS INC (BACK) stock?
IMAC HOLDINGS INC (BACK) has a resistance level at 0.73. Check the full technical report for a detailed analysis of BACK support and resistance levels.
Is IMAC HOLDINGS INC (BACK) expected to grow?
The Revenue of IMAC HOLDINGS INC (BACK) is expected to decline by -100% in the next year. Check the estimates tab for more information on the BACK EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy IMAC HOLDINGS INC (BACK) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BACK, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BACK, evaluating the profitability, health, valuation and growth aspects
- IMAC HOLDINGS INC (BACK) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IMAC HOLDINGS INC (BACK) Sales and EPS estimates to see what analysts future expectations are.
- IMAC HOLDINGS INC (BACK) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IMAC HOLDINGS INC (BACK) Insider and Institutional Ownership to learn about the owners and their transactions.
- IMAC HOLDINGS INC (BACK) Stock Chart to make your own analysis
- IMAC HOLDINGS INC (BACK) Latest news and press-releases to stay up to date.
Does IMAC HOLDINGS INC (BACK) stock pay dividends?
BACK does not pay a dividend.
When does IMAC HOLDINGS INC (BACK) report earnings?
IMAC HOLDINGS INC (BACK) will report earnings on 2025-04-14.
What is the Price/Earnings (PE) ratio of IMAC HOLDINGS INC (BACK)?
IMAC HOLDINGS INC (BACK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.76).
What is the Short Interest ratio of IMAC HOLDINGS INC (BACK) stock?
The outstanding short interest for IMAC HOLDINGS INC (BACK) is 20.47% of its float. Check the ownership tab for more information on the BACK short interest.
BACK Technical Analysis
BACK Financial Highlights
Over the last trailing twelve months BACK reported a non-GAAP Earnings per Share(EPS) of -4.76. The EPS increased by 66.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -993.1% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BACK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to BACK. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 69.42% and a revenue growth -100% for BACK